Posts

Showing posts with the label Lyme Disease market outlook report

Lyme Disease – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030

Image
  Lyme disease is a multi-organ animal-borne disease, caused by bacteria – spirochetes of the Borrelia species classified as Borrelia burgdorferi (Bb) strain (sensu lato). It can manifest as early localized, early disseminated disease, or late disease. Both the innate and adaptive immune systems contribute to the inflammatory response which results in clinical symptoms. Regardless of the clinical presentation, the vast majority of patients who are treated for Lyme disease with short courses of appropriate antibiotics do extremely well. The clinical presentation varies depending on the stage of the illness and includes erthyma migrans, carditis, central nervous system disease, and arthritis. Regardless of the clinical presentation, most patients with Lyme disease have a resolution of their clinical symptoms when treated with appropriate antimicrobials. ·        The incidence of Lyme disease in the United States ranges between 8 to 11.5 cases per 100,0...